Neurontin, while commonly prescribed, isn't the only option available for managing neuropathic pain and seizures. In 2025, several alternatives exist to address these conditions, each offering its unique benefits and side effects profile. From Cymbalta's ability to tackle depression and pain to Lidoderm's targeted relief, exploring these options can help patients and caregivers make informed healthcare decisions.